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DEAN’S RESEARCH NEWSLETTER

Spring 2020

I am particularly gratified to witness the innovative research underway here at New York Medical
College (NYMC). As we face this enormous health crisis, it is through research that we will
advance all of the countries around the world in developing new treatments for COVID-19 and
other serious health issues facing our nation. That is why I am proud to see so many timely
research projects already taking place here for, as we know, research drives clinical practice.
News of some of that invaluable research being conducted by our faculty and students, is
included in this newsletter. I look forward to sharing more updates in future issues.
Facilitating research is very important for both our faculty and students. Christopher S. Leonard,
Ph.D., professor of physiology, is chairing the Research Support Services Committee, which will
be working to identify how we can further support research. The Committee recently conducted
a survey of our faculty to gain their vital input as we seek ways to improve the research and
scholarship environment at NYMC.
Congratulations to everyone as you continue your research, collaborations and success in securing grants. Be safe and well.

Jerry L. Nadler, M.D., MACP, FAHA, FACE
Dean of the School of Medicine				
Professor of Medicine and Pharmacology

Recommended Article

in the Westchester County Business Journal
Seeking a Cure: Regeneron and NYMC
in COVID-19 Study
Salomon Amar, D.D.S., Ph.D, vice president for research &
professor of pharmacology, microbiology and immunology
Lawrence J. DeLorenzo, M.D., professor of medicine
Donald S. Chen, M.D., assistant professor of medicine
Alison T. Lennox, M.D., clinical assistant professor of
medicine and pediatrics

COVID-19 RESEARCH
NYMC Collaborates with Regeneron for COVID-19 Clinical Drug Trials
When COVID-19 first hit our shores with no vaccine nor proven
drug treatment in sight, new innovative collaborations sprouted up
across the nation, as leading research institutions, pharmaceutical
companies and hospitals joined forces to find a solution fast. Among
them—a collaborative clinical drug trial by NYMC and Regeneron
Pharmaceuticals launched at Westchester Medical Center (WMC) within
the first few weeks. Seeking a partner with whom to establish a clinical
drug trial that could be used to treat critically ill patients with COVID-19,
Regeneron proposed the collaboration—not only for NYMC’s state-ofthe-art virology labs and internationally regarded experts—but because
of the College’s decades-long involvement in the annual development of
the influenza vaccine.

Salomon Amar, D.D.S., Ph.D.

“As a result of COVID-19, people from across all sectors are coming together to help drive efforts to find a treatment and stop
the virus.” says Salomon Amar, D.D.S., Ph.D., vice president for research at NYMC and provost for biomedical research at Touro
College and University System (TCUS). “In any situation, wherever there is darkness—any negative impact—there is always
some light. For the COVID-19 crisis, this new collaborative spirit represents that light.” Read full article on the clinical drug trials.

Medical Student Part of Project to Test NYC Subways for COVID-19
Rising fourth-year medical student Ebrahim Afshinnekoo’s passion
for research has long been in evidence. So it came as no surprise that
when the COVID-19 pandemic hit New York. Mr. Afshinnekoo rose to
the occasion as part of a team to test New York City (NYC) hospitals
and urban environments for the prevalence of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and other viruses and to address
the limitations in testing.

Ebrahim Afshinnekoo, left

“It was an ‘all hands on deck’ situation in the lab, and I jumped at the
opportunity to do my part,” says Mr. Afshinnekoo. “With clinical rotations
suspended, I wasn’t able to help support our health care workers on the
front lines, but I was able to help fight the pandemic through this research.”

It was during his undergraduate years at Macaulay Honors College at the City University of New York (CUNY) - Queens College
that Mr. Afshinnekoo first began working with Christopher Mason, Ph.D., associate professor at Weill Cornell Medicine, on a project
to collect DNA from the NYC subway system to study the urban microbiome and create a molecular portrait of NYC. That project
later led him and Dr. Mason, in 2015, to co-found the MetaSUB (metagenomics of subways and urban biomes) International
Consortium. Mr. Afshinnekoo currently serves as clinical director for MetaSUB.
“An event such as the COVID-19 pandemic was one of the reasons we founded the consortium, so that we could utilize nextgeneration sequencing technology to catalog and characterize urban microbiomes and aid public health officials and clinicians
with surveillance and tracing,” says Mr. Afshinnekoo. “So when COVID-19 hit, we galvanized our resources to collect samples and
try to adjust our protocols (which had been DNA-based sampling and analysis) to include RNA in order to detect SARS-CoV-2.”
Read full article on Ebrahim Afshinnekoo’s work.
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NYMC Faculty Member Joins Team to Develop Alternate Form of Ventilation
For the past several weeks, Albert Kwon, M.D., assistant professor
of anesthesiology, has taken a step back from his critical role as an
anesthesiologist at WMC to work on a critically important research project
with equally lifesaving prospects.
As the acute need for ventilators amid the COVID-19 health crisis emerged
and with the potential looming for a shortfall of thousands of units, a group
of MIT engineers, teaming with doctors with clinical experience in treating
respiratory conditions, looked to a ten-year-old design for an inexpensive
alternative for ventilation as the possible solution. The alternate design
sought to automate the standard manual process of squeezing by hand
an emergency resuscitator bag (known as an Ambu bag), currently readily
available in large numbers at hospitals.

Albert Kwon, M.D., center

Dr. Kwon, an MIT alumnus, first heard about the project during a call to a professional colleague on an unrelated matter
and was quickly recruited to become part of team. Initially he was tasked with conducting an animal study to validate the
functionalities of a ventilator. Read full article on the project.

GRANTS & DEPARTMENT RESEARCH
Nearly $1 Million Grant to Again Support NYMC in Developing Flu Vaccine
As the COVID-19 pandemic continues, researchers around the world are scrambling to
develop a vaccine. More than a century ago, the 1918 influenza pandemic, which killed 50
to 100 million people worldwide, sparked similar vaccine-related research, and today, the
Centers for Disease Control (CDC) estimates that the influenza vaccine reduces the risk of
flu illness by between 40 percent and 60 percent.
NYMC has been at the forefront in aiding in the development of the annual influenza vaccine
for decades. Each year, NYMC researchers develop two to four high-yield, high-growth
influenza virus reassortants as ‘seed’ viruses for the production of the world’s annual supply
of influenza vaccine—some 400 million doses worldwide.
This year, that research will be supported by a $956,604 grant from the International
Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Since 2002, NYMC
has annually received similar funding for influenza vaccine development from IFPMA and the Biomedical Advanced Research
and Development Authority (BARDA), totaling approximately $18 million to support this important research.
Doris J. Bucher, Ph.D.

“Every year is critical, with the influenza vaccine preventing thousands of deaths and several hundred thousand
hospitalizations,” says Doris J. Bucher, Ph.D., associate professor of microbiology and immunology, who has overseen
the laboratory and directed the production of the seed viruses at NYMC since 2004. “We also developed the seed viruses
for the 2009 swine flu vaccine. Because our approach was more rapid than a competing methodology, it resulted in a better
product, which was recognized by the vaccine manufacturers with increased funding.” Read full article on influenza vaccine
development.
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Grants Corner
Mitchell S. Cairo, M.D., professor of pediatrics, medicine, pathology, microbiology and immunology and cell biology
and anatomy and co-chief of hematology, will serve as PI for a $504,183 grant from Jazz Pharmaceuticals, Inc. for a
“Pilot Study to Determine the Safety of Defibrotide in Children with High Risk Kawasaki Disease.”
Abhay Dhand, M.D., associate professor of medicine, has received a $38,750 grant over the course of three years
from Tetraphase Pharmaceuticals for “In-vitro Susceptibility of Eravacyline Against Multi-Drug Resistant Enterococci and
Enterobacteriaceae.”
Xiang Dong, M.D., clinical associate professor of surgery, has been awarded a $303,924 grant from The MT Group,
Inc. for “Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and
Personalized Management of Patients.”
Allen J. Dozor, M.D., professor of pediatrics, has been awarded a $21,205 grant by AstraZeneca Pharmaceuticals to
conduct a “multicenter, double-blind, randomized, placebo-controlled, parallel group, Phase 3, safety extension study to
evaluate the safety and tolerability of Tezepelumab in adults and adolescents with severe uncontrolled asthma.”
Marina Holz, Ph.D., dean of the Graduate School of Basic Medical Sciences and professor of cell biology and anatomy,
has received a $30,000 grant from the American Cancer Society to support “Tamoxifen Signaling in ER-negative Breast
Cancer.”
Jeontaik J. Kwon, M.D., M.S.E., assistant professor of surgery, has been awarded a $26,780 grant from Thomas
Jefferson University in support of “Evaluation of a Closed Incision Negative Pressure Dressing (PREVENA) To Prevent
Lower Extremity Amputation Wound Complications.”
Edmund F. Lagamma, M.D. ’76, professor of pediatrics, biochemistry and molecular biology, has been awarded
a $24,020 grant from Aerogen Pharma for a study to “determine the efficacy, safety and tolerability of AeroFactTM
(Aerosolized SF-RI 1) administered by nCPAP vs nCPAP alone in treatment of preterm infants at risk for worsening
respiratory distress syndrome.”
Xiu-Min Li, M.D., M.S., professor of microbiology and immunology and otolaryngology, received a $55,000 grant over
the course of two years from the Moss Family Foundation for “Mechanisms Underlying the Effects of TCM Dietary
Supplements on Improving Gastrointestinal Symptoms Related to Eosinophilic Esophagitis: Preclinical Study.”

Student Research Opportunities
While many NYMC faculty have had to suspend their research activities to prioritize patient care, those not on the front lines
of the pandemic are able to dedicate more time to student mentoring. In addition, numerous COVID-19-related projects
have emerged and welcome student involvement. These projects have been met with great enthusiasm as students from
pre-clinical and clinical years have filled the available spots within days. To help manage the outpouring of student interest,
student leadership positions have emerged to facilitate medical student contributions during this challenging time.
Bertie Zhang, a current third-year medical student, has been coordinating and recruiting for COVID-19 research projects
based at NYC Health + Hospitals/Metropolitan. Through close collaboration with hospital administration, project leads and
NYMC leadership, she has played a key role in connecting student researchers to multiple projects in the Department of
Medicine and Department of Emergency Medicine. Current Metropolitan projects include an inpatient COVID-19 database,
a disposition follow-up QI project and a multicenter COVID-19 study. A survey of all NYMC-affiliated faculty is underway to
identify all such opportunities for student research. An updated list of available projects (COVID-19-related and non-related)
for School of Medicine (SOM) students will be posted on LEO/LCMS+ under the SOM-Research heading. In addition, a link to
the Google sheet will be sent directly to all students.
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Dr. Jonathan Fisher Receives $1.375 million Grant to Study Enhancing
Sensory Acuity with Ultrasound
Jonathan Fisher, Ph.D., assistant professor of physiology, recently received a fouryear $1.375 million grant from the National Institutes of Health (NIH) to support his
research on using ultrasound to enhance sensory acuity.
“The surface of our brain, the cerebral cortex, contains a ‘map’ of the senses. This
map is ‘plastic,’ and can change depending on your experiences. When you practice
the piano, for example, the regions on your brain that represent the fingers change.
If a limb is amputated, the topology of the sensory map may change. Noninvasive,
low-intensity focused ultrasound (FUS) can adjust this mapping—however nobody
really knows how, why or how far we can take this technology,” says Dr. Fisher. “The
applications range from therapy to science fiction.”
“Brain stimulation technology is actually a staple of neurotherapeutics. Transcranial magnetic stimulation, for example,
is ubiquitous and has been used for everything from assessing brain injury to treating depression and eating disorders.
Deep brain stimulation can be used to treat epilepsy or essential tremor. However, those technologies affect golf ball-sized
volumes of the brain. Ultrasound can be focused into beams thinner than a grain of rice. Imagine how finely we could tune the
treatment.”
According to Dr. Fisher, despite the allure of FUS as a modulation approach, many aspects of the technology relevant to
translational capability are unclear, and conflicting results have been reported for even macroscopic effects. The federal
funds, which will support the project, “Neural mechanisms of ultrasound-induced enhancement of sensory acuity,” will allow
Dr. Fisher to characterize the transformation of targeted stimulation to behavioral changes.
“By leveraging novel optical tools and behavioral experimental approaches, the proposed research will address key
knowledge gaps that currently limit development and refinement of FUS neuromodulation for use in humans.”

NYMC Recent Graduate’s Novel Research May Improve Ability to Predict
Outcomes for Older Neurosurgery Patients
Having authored 18 peer-reviewed publications and having mentored as many as 15
junior medical students at a time, Matthew McIntyre, M.D. ’20, who graduated in April,
is poised to become a rising star in the field of neurosurgical research.
Inside the bustling hallways of NYMC, you may have found Matthew McIntyre helping
a junior medical student to design a study or to review their data set. At first glance,
it’s an ordinary tableau that can be found in almost any lab at a major health sciences
college. However, upon closer inspection, what makes this scene extraordinary is that
at the time, Dr. McIntyre was still just a medical student himself.
The team Dr. McIntyre is currently mentoring is looking at frailty—a state of reduced physiologic reserve—as a measure to
predict outcomes in neurosurgical patients.
Though age and frailty are highly correlated, Dr. McIntyre explains that different studies have shown frailty to be independent
of age. As a result, current prediction models are not comprehensive enough to give neurosurgeons a definite understanding
of a patient’s anticipated outcome, but it is Dr. McIntyre’s goal to change that. Read full article about Dr. McIntyre.
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Research Support Services Committee Update
The Research Support Services Committee (RSSC) is a standing
committee of the NYMC faculty charged with ensuring that research
services are providing appropriate support to the faculty. Historically, the
committee has monitored administrative services, such as purchasing
and research administration, and has worked with other committees
essential to research activities to improve library and IT services and
core facilities. The committee also provided key input to the Research
Advancement Task Force, which was convened by Alan Kadish, M.D.,
president of NYMC and TCUS, in 2011 and developed a focused plan
for increasing NYMC research and proposed improvements to research
support processes, several of which have been implemented, including
overhauling the purchasing system. The RSSC reports to the Executive
Committee of the Faculty Senate and the NYMC SOM Dean.
At the January meeting, with support from the executive committee and SOM Dean Jerry Nadler, it was agreed to survey the
faculty to better understand their current and future research needs. After collecting and reworking materials from several
sources, including the prior Research Task Force survey, the RSSC implemented and launched a new survey on the Qualtrics
platform with essential contributions from Lenore Carpinelli in the SOM dean’s office.
The survey is now closed, and we thank the many faculty who took their valuable time to contribute. There were 120
responses from faculty in 21 of 27 basic science and clinical departments in the SOM, Graduate School of Basic Medical
Sciences and School of Health Sciences and Practice. Survey results are being analyzed, but some preliminary notes of
interest are:
• Useful suggestions to increase extramural funding successes
• Excellent rating for quality of Laboratory Animal Resources, which is the most-used core
• Good/Average rating for Core Histology Facility, which is second most-used
• Excellent/Good rating for q-PCR facility, which is third most-used
• High level of support for implementing automated monitoring of ultra-freezers, freezers, incubators, etc.
• ~75% of faculty would participate in an automated NYMC network data backup service
Once analyzed, the RSSC will use this information to further improve research operations by following up on issues
raised, and by making recommendations to the executive committee and Dean Nadler. We will also share the data with other
divisions as appropriate, with the anticipation these findings will be used for strategic planning.
Reporting for the RSSC, Christopher S. Leonard, Ph.D., chair

Research Information Updates/NIH Links
Bridge & Seed Funding Grant Programs: The deadline for submissions of proposals under the Bridge and Seed
Funding Grant Programs has been extended until May 15, 2020. Special attention will be given to Seed Grant
applications covering COVID-19. Program guidelines, instructions and application forms are available here.
Weekly NIH Announcements and NIH Funding Opportunities
NYMC Office of Research Administration: Learn more about funding opportunities here.
Research Gate: Read about recent publications here.
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